High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles
The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inver...
Gespeichert in:
Veröffentlicht in: | International journal of pharmaceutics 2010-08, Vol.395 (1), p.290-297 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 297 |
---|---|
container_issue | 1 |
container_start_page | 290 |
container_title | International journal of pharmaceutics |
container_volume | 395 |
creator | Mulet, Xavier Kennedy, Danielle F. Conn, Charlotte E. Hawley, Adrian Drummond, Calum J. |
description | The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inverse bicontinuous cubic and inverse hexagonal liquid crystalline nanoparticles loaded with 10 commonly used therapeutic agents at increasing concentration. The dispersions are prepared using automated apparatus to create different concentrations and phases using novel protocols. We are able to characterise each stabilised nanoparticle dispersion using a range of methodologies including small angle X-ray scattering, particle sizing and drug partitioning. With this information we are able to assess which drug delivery vehicle is preferred for each drug and at which concentration the drug should be loaded to ensure maximum payload and to retain particle integrity. |
doi_str_mv | 10.1016/j.ijpharm.2010.05.029 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754563221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S037851731000390X</els_id><sourcerecordid>754563221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-9fc42ba62205ccb800500f5f98937c4e740c7e7f9084bb652268fa4d1a2d07e83</originalsourceid><addsrcrecordid>eNqFkU1rHDEMhk1paDZpf0LLXEpPs5XtsT1zKiU0SSHQS3o2Ho9mx8t81R8L-ffxdjftMSAQEs8rCb2EfKSwpUDl1_3W7dfB-GnLIPdAbIE1b8iG1oqXvFLyLdkAV3UpqOKX5CqEPQBIRvk7cslA1KAauSHp3u2GIg5-SbthTbFYPa7Gm-iWuTBzV9i8w9iI3oVTc-kLM62DyzE6W8xmXkL0ycbksftbZn10No0mYtH5tCs6HN0B_VNxwMHZEcN7ctGbMeCHc74mv29_PN7clw-_7n7efH8obcVkLJs-59ZIlu-1tq0BBEAv-qZuuLIVqgqsQtU3UFdtKwVjsu5N1VHDOlBY82vy5TR39cufhCHqyQWL42hmXFLQSlRCcpaf8irJeVNT3hxJcSKtX0Lw2OvVu8n4J01BH63Re322Rh-t0SB0tibrPp03pHbC7p_qxYsMfD4DJlgz9t7M1oX_HAcq8sDMfTtxmD93cOh1sA5ni53zaKPuFvfKKc8ttbIP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733981391</pqid></control><display><type>article</type><title>High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Mulet, Xavier ; Kennedy, Danielle F. ; Conn, Charlotte E. ; Hawley, Adrian ; Drummond, Calum J.</creator><creatorcontrib>Mulet, Xavier ; Kennedy, Danielle F. ; Conn, Charlotte E. ; Hawley, Adrian ; Drummond, Calum J.</creatorcontrib><description>The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inverse bicontinuous cubic and inverse hexagonal liquid crystalline nanoparticles loaded with 10 commonly used therapeutic agents at increasing concentration. The dispersions are prepared using automated apparatus to create different concentrations and phases using novel protocols. We are able to characterise each stabilised nanoparticle dispersion using a range of methodologies including small angle X-ray scattering, particle sizing and drug partitioning. With this information we are able to assess which drug delivery vehicle is preferred for each drug and at which concentration the drug should be loaded to ensure maximum payload and to retain particle integrity.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2010.05.029</identifier><identifier>PMID: 20580796</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Automation, Laboratory ; Biological and medical sciences ; Chemistry, Pharmaceutical ; Cubosome ; Drug Carriers ; Drug delivery ; Drug Stability ; Fatty Alcohols - chemistry ; General pharmacology ; Glycerides - chemistry ; Hexosome ; High-throughput ; High-Throughput Screening Assays ; Liquid Crystals - chemistry ; Lyotropic liquid crystal ; Medical sciences ; Nanoparticles ; Particle Size ; Pharmaceutical Preparations - chemistry ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Scattering, Small Angle ; Solubility ; Spectrophotometry ; Technology, Pharmaceutical - methods ; X-Ray Diffraction</subject><ispartof>International journal of pharmaceutics, 2010-08, Vol.395 (1), p.290-297</ispartof><rights>2010</rights><rights>2015 INIST-CNRS</rights><rights>Crown Copyright (c) 2010. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-9fc42ba62205ccb800500f5f98937c4e740c7e7f9084bb652268fa4d1a2d07e83</citedby><cites>FETCH-LOGICAL-c426t-9fc42ba62205ccb800500f5f98937c4e740c7e7f9084bb652268fa4d1a2d07e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2010.05.029$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23015201$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20580796$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mulet, Xavier</creatorcontrib><creatorcontrib>Kennedy, Danielle F.</creatorcontrib><creatorcontrib>Conn, Charlotte E.</creatorcontrib><creatorcontrib>Hawley, Adrian</creatorcontrib><creatorcontrib>Drummond, Calum J.</creatorcontrib><title>High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inverse bicontinuous cubic and inverse hexagonal liquid crystalline nanoparticles loaded with 10 commonly used therapeutic agents at increasing concentration. The dispersions are prepared using automated apparatus to create different concentrations and phases using novel protocols. We are able to characterise each stabilised nanoparticle dispersion using a range of methodologies including small angle X-ray scattering, particle sizing and drug partitioning. With this information we are able to assess which drug delivery vehicle is preferred for each drug and at which concentration the drug should be loaded to ensure maximum payload and to retain particle integrity.</description><subject>Automation, Laboratory</subject><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical</subject><subject>Cubosome</subject><subject>Drug Carriers</subject><subject>Drug delivery</subject><subject>Drug Stability</subject><subject>Fatty Alcohols - chemistry</subject><subject>General pharmacology</subject><subject>Glycerides - chemistry</subject><subject>Hexosome</subject><subject>High-throughput</subject><subject>High-Throughput Screening Assays</subject><subject>Liquid Crystals - chemistry</subject><subject>Lyotropic liquid crystal</subject><subject>Medical sciences</subject><subject>Nanoparticles</subject><subject>Particle Size</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Scattering, Small Angle</subject><subject>Solubility</subject><subject>Spectrophotometry</subject><subject>Technology, Pharmaceutical - methods</subject><subject>X-Ray Diffraction</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1rHDEMhk1paDZpf0LLXEpPs5XtsT1zKiU0SSHQS3o2Ho9mx8t81R8L-ffxdjftMSAQEs8rCb2EfKSwpUDl1_3W7dfB-GnLIPdAbIE1b8iG1oqXvFLyLdkAV3UpqOKX5CqEPQBIRvk7cslA1KAauSHp3u2GIg5-SbthTbFYPa7Gm-iWuTBzV9i8w9iI3oVTc-kLM62DyzE6W8xmXkL0ycbksftbZn10No0mYtH5tCs6HN0B_VNxwMHZEcN7ctGbMeCHc74mv29_PN7clw-_7n7efH8obcVkLJs-59ZIlu-1tq0BBEAv-qZuuLIVqgqsQtU3UFdtKwVjsu5N1VHDOlBY82vy5TR39cufhCHqyQWL42hmXFLQSlRCcpaf8irJeVNT3hxJcSKtX0Lw2OvVu8n4J01BH63Re322Rh-t0SB0tibrPp03pHbC7p_qxYsMfD4DJlgz9t7M1oX_HAcq8sDMfTtxmD93cOh1sA5ni53zaKPuFvfKKc8ttbIP</recordid><startdate>20100816</startdate><enddate>20100816</enddate><creator>Mulet, Xavier</creator><creator>Kennedy, Danielle F.</creator><creator>Conn, Charlotte E.</creator><creator>Hawley, Adrian</creator><creator>Drummond, Calum J.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100816</creationdate><title>High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles</title><author>Mulet, Xavier ; Kennedy, Danielle F. ; Conn, Charlotte E. ; Hawley, Adrian ; Drummond, Calum J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-9fc42ba62205ccb800500f5f98937c4e740c7e7f9084bb652268fa4d1a2d07e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Automation, Laboratory</topic><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical</topic><topic>Cubosome</topic><topic>Drug Carriers</topic><topic>Drug delivery</topic><topic>Drug Stability</topic><topic>Fatty Alcohols - chemistry</topic><topic>General pharmacology</topic><topic>Glycerides - chemistry</topic><topic>Hexosome</topic><topic>High-throughput</topic><topic>High-Throughput Screening Assays</topic><topic>Liquid Crystals - chemistry</topic><topic>Lyotropic liquid crystal</topic><topic>Medical sciences</topic><topic>Nanoparticles</topic><topic>Particle Size</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Scattering, Small Angle</topic><topic>Solubility</topic><topic>Spectrophotometry</topic><topic>Technology, Pharmaceutical - methods</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulet, Xavier</creatorcontrib><creatorcontrib>Kennedy, Danielle F.</creatorcontrib><creatorcontrib>Conn, Charlotte E.</creatorcontrib><creatorcontrib>Hawley, Adrian</creatorcontrib><creatorcontrib>Drummond, Calum J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulet, Xavier</au><au>Kennedy, Danielle F.</au><au>Conn, Charlotte E.</au><au>Hawley, Adrian</au><au>Drummond, Calum J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2010-08-16</date><risdate>2010</risdate><volume>395</volume><issue>1</issue><spage>290</spage><epage>297</epage><pages>290-297</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>The preparation, characterisation and assessment of drug delivery vehicles is typically a slow and complex process. Here we present a nanostructured nanoparticle system that can be prepared and characterised in a high-throughput fashion. In particular we use phytantriol and Myverol™ to prepare inverse bicontinuous cubic and inverse hexagonal liquid crystalline nanoparticles loaded with 10 commonly used therapeutic agents at increasing concentration. The dispersions are prepared using automated apparatus to create different concentrations and phases using novel protocols. We are able to characterise each stabilised nanoparticle dispersion using a range of methodologies including small angle X-ray scattering, particle sizing and drug partitioning. With this information we are able to assess which drug delivery vehicle is preferred for each drug and at which concentration the drug should be loaded to ensure maximum payload and to retain particle integrity.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>20580796</pmid><doi>10.1016/j.ijpharm.2010.05.029</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-5173 |
ispartof | International journal of pharmaceutics, 2010-08, Vol.395 (1), p.290-297 |
issn | 0378-5173 1873-3476 |
language | eng |
recordid | cdi_proquest_miscellaneous_754563221 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Automation, Laboratory Biological and medical sciences Chemistry, Pharmaceutical Cubosome Drug Carriers Drug delivery Drug Stability Fatty Alcohols - chemistry General pharmacology Glycerides - chemistry Hexosome High-throughput High-Throughput Screening Assays Liquid Crystals - chemistry Lyotropic liquid crystal Medical sciences Nanoparticles Particle Size Pharmaceutical Preparations - chemistry Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Scattering, Small Angle Solubility Spectrophotometry Technology, Pharmaceutical - methods X-Ray Diffraction |
title | High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T08%3A54%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20throughput%20preparation%20and%20characterisation%20of%20amphiphilic%20nanostructured%20nanoparticulate%20drug%20delivery%20vehicles&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Mulet,%20Xavier&rft.date=2010-08-16&rft.volume=395&rft.issue=1&rft.spage=290&rft.epage=297&rft.pages=290-297&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2010.05.029&rft_dat=%3Cproquest_cross%3E754563221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733981391&rft_id=info:pmid/20580796&rft_els_id=S037851731000390X&rfr_iscdi=true |